Our AMP chemistry-based targeted panel and analysis method enable highly concordant HRD classifications with fewer reads than WGS and other NGS methods, and without requiring paired tumor-normal data or a panel of normals. The HRD module can be combined with any other VariantPlex panel content for simultaneous measurement of HRD, other genomic signatures, and variant calling.
"With a history of driving innovation and collaboration in next generation sequencing (NGS), Integrated DNA Technologies is expanding its Archer portfolio of comprehensive genomic profiling (CGP) solutions to include homologous recombination deficiency (HRD) assessment."